Intuitive Surgical 

$479.22
1134
-$1.05-0.22% Friday 18:03

統計

當日最高
485.05
當日最低
476.7
52週最高
485.05
52週最低
232.27
成交量
2,781
平均成交量
4,888
市值
-
市盈率
1.07
股息收益率
-
股息
-

即將到來

收益

17Oct預期
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
下一個
1.2
1.39
1.59
1.78
預期每股收益
1.641381
實際每股收益
N/A

人們還關注

此列表基於在 Stock Events 上關注 0R29.LSE 的人的關注列表。這不是投資建議。

競爭者

這個列表是基於最近市場事件的分析。這不是投資建議。

關於

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Show more...
首席執行官
Dr. Gary S. Guthart Ph.D.
員工
13676
國家
US
ISIN
US46120E6023

上市公司